Efficacy and safety of ixekizumab in psoriatic arthritis: a retrospective, single-centre, observational study in a real-life clinical setting

Clin Exp Rheumatol. 2020 May-Jun;38(3):581-582. Epub 2020 Feb 4.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Arthritis, Psoriatic / drug therapy*
  • Humans
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • ixekizumab